Bladder Instillation of Liposome Encapsulated OnabotulinumtoxinA Improves Overactive Bladder Symptoms: A Prospective, Multicenter, Double-Blind, Randomized Trial-Reference-Cited by-同舟云学术

Bladder Instillation of Liposome Encapsulated OnabotulinumtoxinA Improves Overactive Bladder Symptoms: A Prospective, Multicenter, Double-Blind, Randomized Trial

Published:2014-12 Issue:6 Volume:192 Page:1743-1749
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Chuang Yao-Chi¹,Kaufmann Jonathan H.²,Chancellor David D.²,Chancellor Michael B.²³,Kuo Hann-Chorng⁴

Affiliation:

1. Department of Urology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University, College of Medicine, Taiwan

2. Lipella Pharmaceuticals, Pittsburgh, Pennsylvania

3. Oakland University-William Beaumont School of Medicine, Royal Oak, Michigan

4. Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference23 articles.

1. The standardisation of terminology of lower urinary tract function: report from the standardization sub-committee of the international continence society;Abrams;Neurourol Urodyn,2002

2. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction;Irwin;BJU Int,2011

3. Overactive bladder syndrome among community-dwelling adults in Taiwan: prevalence, correlates, perception, and treatment seeking;Yu;Urol Int,2006

4. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline;Gormley;J Urol,2012

5. Efficacy and adverse events of antimuscarinics for treating overactive bladder: network meta-analyses;Buser;Eur Urol,2012

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Electroacupuncture versus solifenacin succinate for female overactive bladder: study protocol for a multicentre, randomised, controlled, double-dummy, non-inferiority trial;BMJ Open;2024-09

2. Strategies for Safe Transurethral Injections of Botulinum Toxin into the Bladder Wall;Toxins;2024-06-30

3. A Novel Catalytically Inactive Construct of Botulinum Neurotoxin A (BoNT/A) Directly Inhibits Visceral Sensory Signalling;Toxins;2024-01-07

4. Progress and challenges in intravesical drug delivery;Expert Opinion on Drug Delivery;2024-01-02

5. Current optimal pharmacologic therapies for overactive bladder;Expert Opinion on Pharmacotherapy;2023-10-05